## **Core Concept**
The patient presents with a solitary lung lesion that is malignant, but the organ of origin is unclear. Given his history of thyroidectomy for thyroid cancer, one of the primary considerations is metastatic thyroid cancer. Thyroid cancer can metastasize to the lungs, and this presentation is consistent with a possible metastasis.

## **Why the Correct Answer is Right**
The correct approach involves considering the patient's history of thyroid cancer. Thyroid cancer, particularly differentiated types (such as papillary and follicular thyroid carcinoma), often metastasizes to the lungs. A significant proportion of patients with metastatic thyroid cancer to the lungs can have a relatively indolent course, and treatment may involve radioactive iodine (RAI) therapy, especially if the metastasis is iodine-avid. RAI therapy targets cells that take up iodine, which includes normal thyroid cells and many thyroid cancer cells.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not provided, but typically, incorrect options might include treatments not directly related to thyroid cancer management, such as chemotherapy or targeted therapy without considering RAI therapy.
- **Option B:** Similarly, without specifics, another incorrect option might involve treatments not tailored to the likely diagnosis of metastatic thyroid cancer.
- **Option C:** This option might involve a treatment not directly indicated for metastatic thyroid cancer, such as a specific chemotherapy regimen not typically used as a first-line treatment for iodine-avid metastases.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **radioactive iodine (RAI) therapy** is a treatment option for metastatic thyroid cancer, particularly for lesions that are iodine-avid. This therapy can be effective in managing or treating metastatic disease, especially in patients with a history of thyroid cancer. Uptake of RAI by the tumor cells is a prerequisite for its effectiveness.

## **Correct Answer:** .